CN104740320A - Traditional Chinese medicine composition for treating acne and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating acne and preparation method thereof Download PDFInfo
- Publication number
- CN104740320A CN104740320A CN201510147846.2A CN201510147846A CN104740320A CN 104740320 A CN104740320 A CN 104740320A CN 201510147846 A CN201510147846 A CN 201510147846A CN 104740320 A CN104740320 A CN 104740320A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- acne
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 206010000496 acne Diseases 0.000 title claims abstract description 50
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 16
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 15
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 15
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 15
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 15
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 15
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 240000004922 Vigna radiata Species 0.000 claims abstract description 15
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 15
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 15
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 14
- 206010000503 Acne cystic Diseases 0.000 claims abstract description 5
- 244000111489 Gardenia augusta Species 0.000 claims abstract 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 14
- 244000223014 Syzygium aromaticum Species 0.000 claims description 14
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 14
- 229910052709 silver Inorganic materials 0.000 claims description 14
- 239000004332 silver Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 11
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 9
- 239000000865 liniment Substances 0.000 claims description 9
- 229940040145 liniment Drugs 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 claims description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 claims description 7
- 208000026435 phlegm Diseases 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 229940098465 tincture Drugs 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 229930002330 retinoic acid Natural products 0.000 claims description 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N retinoic acid group Chemical group C\C(=C/C(=O)O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 229960001727 tretinoin Drugs 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000010408 film Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 241000050051 Chelone glabra Species 0.000 claims 3
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims 2
- 229960003321 baicalin Drugs 0.000 claims 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims 2
- 208000024891 symptom Diseases 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 241000416918 Polyphylla Species 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 241000157835 Gardenia Species 0.000 description 10
- 206010040882 skin lesion Diseases 0.000 description 10
- 231100000444 skin lesion Toxicity 0.000 description 10
- 238000003756 stirring Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 7
- 240000004534 Scutellaria baicalensis Species 0.000 description 6
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 6
- 208000031513 cyst Diseases 0.000 description 6
- 208000010201 Exanthema Diseases 0.000 description 5
- 206010037888 Rash pustular Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000005884 exanthem Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000011802 pulverized particle Substances 0.000 description 5
- 208000029561 pustule Diseases 0.000 description 5
- 206010037844 rash Diseases 0.000 description 5
- 208000032544 Cicatrix Diseases 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- 241000207929 Scutellaria Species 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 230000037387 scars Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 206010054107 Nodule Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 244000148064 Enicostema verticillatum Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010000513 Acne pustular Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种治疗痤疮的中药组合物及其制备方法,属于中药领域。The invention relates to a traditional Chinese medicine composition for treating acne and a preparation method thereof, belonging to the field of traditional Chinese medicines.
背景技术Background technique
痤疮为临床上常见的慢性毛囊皮脂腺炎症性皮肤病,中医称之为“肺风粉刺”、“酒刺”等。痤疮一般多发生于青年男女的面部和胸背部,其特征性皮损是与毛囊一致性的丘疹、黑头粉刺、白头粉刺、脓疱、结节等。粉刺进一步发展会演变成各种炎症性皮损,表现为炎性丘疹、脓疱、结节和囊肿,炎症性皮损消退后常常遗留色素沉着、持久性红斑、凹陷性或肥厚性瘢痕,以致病情顽固、缠绵难愈。痤疮是青年人群中最常见的影响美容的皮肤病,患者容易出现自信心受损、尴尬、抑郁等心理问题,造成社交和就业障碍等。Acne is a clinically common chronic pilosebaceous gland inflammatory skin disease, which is called "lung wind acne", "wine thorn" etc. in traditional Chinese medicine. Acne generally occurs on the face, chest and back of young men and women, and its characteristic skin lesions are papules, blackheads, whiteheads, pustules, and nodules consistent with hair follicles. Acne further develops into various inflammatory skin lesions, manifested as inflammatory papules, pustules, nodules and cysts. Pigmentation, persistent erythema, depressed or hypertrophic scars are often left behind after the inflammatory lesions subside, resulting in The condition is stubborn and lingering. Acne is the most common skin disease that affects beauty among young people. Patients are prone to psychological problems such as impaired self-confidence, embarrassment, and depression, resulting in social and employment barriers.
痤疮发病原因及发病机理较复杂,西医认为这是一种多因素疾病,主要与雄激素、皮脂分泌增加、微生物、炎症损害及免疫、遗传、环境、日常生活习惯等有关。中医认为此病常由内热炽盛、外感风邪所致,按中医辨证分为肺经风热、肠胃湿热、痰瘀互结三型。The etiology and pathogenesis of acne are complex. Western medicine believes that it is a multifactorial disease, which is mainly related to androgen, increased sebum secretion, microorganisms, inflammatory damage, immunity, heredity, environment, and daily life habits. Traditional Chinese medicine believes that this disease is often caused by internal heat and exogenous pathogenic factors. According to TCM syndrome differentiation, it can be divided into three types: wind-heat in the lung meridian, damp-heat in the stomach, and mixed phlegm and blood stasis.
目前临床上多采用维A酸类药物、抗生素、激素等治疗痤疮,早期疗效尚可,但对于痤疮后期的囊肿、瘢痕等缺乏疗效且有多种副作用以及易复发等缺点。中医药对此病疗效突出,但顽固性痤疮因其邪气深痼,口服中药对于局部病变往往治疗周期较长。因此,开发一种安全有效治疗痤疮尤其是顽固性痤疮的产品是痤疮患者的迫切需求。At present, retinoic acid drugs, antibiotics, hormones, etc. are often used clinically to treat acne. The early curative effect is acceptable, but it lacks curative effect on cysts and scars in the later stage of acne, and has many side effects and easy recurrence. Traditional Chinese medicine has an outstanding curative effect on this disease, but intractable acne has a long treatment cycle for local lesions because of its deep evil. Therefore, it is an urgent need for acne patients to develop a safe and effective product for treating acne, especially intractable acne.
发明内容Contents of the invention
本发明的目的在于提供一种可以安全有效治疗痤疮的中药组合物及其制备方法和用途。The object of the present invention is to provide a traditional Chinese medicine composition which can safely and effectively treat acne, its preparation method and application.
本发明提供了一种治疗痤疮的中药组合物,它是由含有下述重量配比的原料药制备而成的制剂:The invention provides a traditional Chinese medicine composition for treating acne, which is a preparation prepared from raw materials containing the following weight ratios:
桃花16-22份,冬瓜子15-25份,白丁香18-23份,山慈菇15-25份,重楼15-25份,丹参40-60份,白芷40-60份,白鲜皮15-25份,硫磺粉8-13份,黄芩10-18份,栀子12-18份,银花12-20份,珍珠粉15-30份,绿豆15-25份。16-22 parts of peach blossom, 15-25 parts of winter melon seeds, 18-23 parts of white clove, 15-25 parts of Shanzi mushroom, 15-25 parts of Chonglou, 40-60 parts of salvia miltiorrhiza, 40-60 parts of Angelica dahurica, white fresh skin 15-25 parts, 8-13 parts of sulfur powder, 10-18 parts of skullcap, 12-18 parts of gardenia, 12-20 parts of silver flower, 15-30 parts of pearl powder, 15-25 parts of mung bean.
进一步优选地,它是由下述重量配比的原料药制备而成的制剂:Further preferably, it is a preparation prepared from raw materials in the following weight ratio:
桃花16-22份,冬瓜子15-25份,白丁香18-23份,山慈菇15-25份,重楼15-25份,丹参40-60份,白芷40-60份,白鲜皮15-25份,硫磺粉8-13份,黄芩10-18份,栀子12-18份,银花12-20份,珍珠粉15-30份,绿豆15-25份。16-22 parts of peach blossom, 15-25 parts of winter melon seeds, 18-23 parts of white clove, 15-25 parts of Shanzi mushroom, 15-25 parts of Chonglou, 40-60 parts of salvia miltiorrhiza, 40-60 parts of Angelica dahurica, white fresh skin 15-25 parts, 8-13 parts of sulfur powder, 10-18 parts of skullcap, 12-18 parts of gardenia, 12-20 parts of silver flower, 15-30 parts of pearl powder, 15-25 parts of mung bean.
更进一步优选地,它是由下述重量配比的原料药制备而成的制剂:More preferably, it is a preparation prepared from raw materials in the following weight ratio:
桃花20份,冬瓜子20份,白丁香20份,山慈菇20份,重楼20份,丹参40份,白芷40份,白藓皮20份,硫磺粉10份,黄芩15份,栀子15,份,银花15份,珍珠粉20份,绿豆20份。20 parts of peach blossom, 20 parts of winter melon seeds, 20 parts of white clove, 20 parts of Shanzi mushroom, 20 parts of Chonglou, 40 parts of salvia miltiorrhiza, 40 parts of angelica dahurica, 20 parts of white moss bark, 10 parts of sulfur powder, 15 parts of skullcap, gardenia 15 parts, silver flower 15 parts, pearl powder 20 parts, mung beans 20 parts.
本发明组合物是由桃花、冬瓜子、白丁香、山慈菇、重楼、丹参、白芷、白鲜皮、硫磺粉、黄芩、栀子、银花、珍珠粉、绿豆的原生药粉、或水或有机溶剂提取物为活性成分,加入药学上可接受的辅料或辅助性成分制备而成的外用制剂。其中,所述的辅助性成分为维生素A酸。The composition of the present invention is composed of peach blossom, wax gourd seeds, white clove, mountain Arrowhead, chrysanthemum, salvia miltiorrhiza, angelica, white fresh skin, sulfur powder, scutellaria baicalensis, gardenia, silver flower, pearl powder, mung bean, or water. Or an external preparation prepared by adding pharmaceutically acceptable adjuvants or auxiliary ingredients as the active ingredient with an organic solvent extract. Wherein, the auxiliary component is vitamin A acid.
其中,所述的外用制剂的剂型为酊剂、膏剂、凝胶剂、洗剂、搽剂、乳液、膜剂。Wherein, the dosage form of the external preparation is tincture, ointment, gel, lotion, liniment, emulsion, film.
本发明还提供了一种所述的中药组合物的制备方法,它包括如下步骤:The present invention also provides a kind of preparation method of described Chinese medicine composition, and it comprises the steps:
a、称取各重量配比的原料药;a, take the raw material medicine of each weight ratio;
b、打粉或加入水或有机溶剂提取,加入药学上可接受的辅料或辅助性成分制备而成的外用制剂。b. External preparation prepared by powdering or adding water or organic solvent for extraction, and adding pharmaceutically acceptable excipients or auxiliary ingredients.
其中,所述的有机溶剂为乙醇。Wherein, the organic solvent is ethanol.
本发明还提供了所述中药组合物在制备具有治疗痤疮功效的药物或化妆品中的用途。The invention also provides the application of the traditional Chinese medicine composition in the preparation of medicines or cosmetics with the effect of treating acne.
其中,所述痤疮为顽固性痤疮,如脓包型性痤疮、囊肿性痤疮。Wherein, the acne is intractable acne, such as pustular acne and cystic acne.
更进一步地,所述痤疮为中医的痰瘀互结型痤疮。Furthermore, the acne is acne of phlegm and blood stasis in traditional Chinese medicine.
本发明提供的中药组合物配伍精当,各药味相辅相成,对缓解痤疮尤其是顽固性痤疮包括化脓性、囊肿性痤疮患者病情疗效显著,可改善痤疮囊肿、瘢痕,有效治疗中医的痰瘀互结型痤疮。对防治痤疮的复发以及复发后的症状减轻有一定疗效。而且本发明的中药组合物以天然中草药为原料,可安全使用。The traditional Chinese medicine composition provided by the present invention is well compatible, and the flavors of the medicines complement each other. It has a significant effect on relieving acne, especially intractable acne, including suppurative and cystic acne, and can improve acne cysts and scars, and effectively treat the phlegm and blood stasis in traditional Chinese medicine. acne. It has a certain effect on the prevention and treatment of acne recurrence and the relief of symptoms after recurrence. Moreover, the traditional Chinese medicine composition of the present invention uses natural Chinese herbal medicines as raw materials and can be used safely.
具体实施方式Detailed ways
下面以实施例作进一步说明,但本发明不局限于这些实施例。The following examples are used for further description, but the present invention is not limited to these examples.
实施例1本发明面膜制备Embodiment 1 facial mask preparation of the present invention
处方:桃花20g,冬瓜子20g,白丁香20g,山慈菇20g,重楼20g,丹参40g、白芷40g,白藓皮20g,硫磺粉10g,黄芩15g,栀子15g,银花15g,珍珠粉20g,绿豆20g。Prescription: 20g of peach blossom, 20g of winter melon seeds, 20g of white clove, 20g of Shanzi mushroom, 20g of Chonglou, 40g of salvia miltiorrhiza, 40g of angelica dahurica, 20g of white moss skin, 10g of sulfur powder, 15g of skullcap, 15g of gardenia, 15g of silver flower, pearl powder 20g, mung beans 20g.
制备方法:Preparation:
将上述中药成分按照重量配比称取,磨粉,粉碎后粒径控制在50-90um,置于容器中,加入蛋黄2-3粒搅拌均匀,再加入蜂蜜100ml,纯水400ml,搅拌均匀即可得到本发明面膜。Weigh the above-mentioned traditional Chinese medicine ingredients according to the weight ratio, grind them into powder, control the particle size at 50-90um after crushing, put them in a container, add 2-3 egg yolks and stir evenly, then add 100ml of honey, 400ml of pure water, stir evenly and serve The facial mask of the present invention can be obtained.
使用方法:Instructions:
将上述制备好的药均匀涂抹于脸上,约二十分钟后,再用清水冲洗干净即可。Apply the above prepared medicine evenly on the face, and after about 20 minutes, rinse it off with clean water.
实施例2本发明软膏剂制备Embodiment 2 ointment preparation of the present invention
(1)将人体可以接受的辅料成分甘油50g、硬脂酸100g、三乙醇胺30g、液状石蜡100g、石蜡60g、羟苯乙酯10g、纯水500ml作为辅料,加热融化后,搅拌均匀并冷凝,即可得到软膏型基质。(1) Use 50g of glycerin, 100g of stearic acid, 30g of triethanolamine, 100g of liquid paraffin, 60g of paraffin, 10g of ethylparaben, and 500ml of pure water as auxiliary materials, which are acceptable to the human body. After heating and melting, stir evenly and condense, An ointment-type base can be obtained.
(2)按下述重量配比称取各中药成分:桃花20g,冬瓜子20g,白丁香20g,山慈菇20g,重楼20g,丹参40g、白芷40g,白藓皮20g,硫磺粉10g,黄芩15g,栀子15g,银花15g,珍珠粉20g,绿豆20g。(2) each Chinese medicine composition is taken by following weight ratio: peach blossom 20g, wax gourd seed 20g, white clove 20g, mountain arrowhead 20g, polyphyllum 20g, salvia miltiorrhiza 40g, angelica dahurica 40g, white moss bark 20g, sulfur powder 10g, Scutellaria baicalensis 15g, gardenia 15g, silver flower 15g, pearl powder 20g, mung bean 20g.
将中药成分粉碎后加水或取得到提取物,干燥,再次粉碎,粉碎粒径控制在50-90um,即可得到活性成分原料药。Add water or obtain the extract after pulverizing the traditional Chinese medicine components, dry, pulverize again, and control the pulverized particle size to 50-90um, and then the active ingredient raw material drug can be obtained.
(3)将(2)得到的原料药加入(1)所得的基质中充分搅拌均匀,即可制成软膏制剂。(3) Add the crude drug obtained in (2) into the matrix obtained in (1) and stir well to make an ointment preparation.
使用方法:将上述制备好的软膏制剂均匀涂抹于脸上,约二十分钟后,再用清水冲洗干净即可。How to use: Apply the ointment prepared above evenly on the face, and rinse it off with water after about 20 minutes.
实施例3本发明乳膏剂制备Embodiment 3 preparation of emulsifiable paste of the present invention
(1)将聚丙烯酸50g、三乙醇胺5g、乙二胺四乙酸二钠2g、丙二醇200g、苯甲酸2g、纯水500ml置于容器中,加热熔化,搅拌均匀并冷凝,得到乳膏剂基质;(1) 50 g of polyacrylic acid, 5 g of triethanolamine, 2 g of disodium edetate, 200 g of propylene glycol, 2 g of benzoic acid, and 500 ml of pure water are placed in a container, heated and melted, stirred evenly and condensed to obtain a cream base;
(2)按下述重量配比称取各中药成分:桃花20g,冬瓜子20g,白丁香20g,山慈菇20g,重楼20g,丹参40g、白芷40g,白藓皮20g,硫磺粉10g,黄芩15g,栀子15g,银花15g,珍珠粉20g,绿豆20g。(2) each Chinese medicine composition is taken by following weight ratio: peach blossom 20g, wax gourd seed 20g, white clove 20g, mountain arrowhead 20g, polyphyllum 20g, salvia miltiorrhiza 40g, angelica dahurica 40g, white moss bark 20g, sulfur powder 10g, Scutellaria baicalensis 15g, gardenia 15g, silver flower 15g, pearl powder 20g, mung bean 20g.
将中药成分粉碎后加乙醇提取得到提取物,干燥,再次粉碎,粉碎粒径控制在50-90um,即可得到活性成分原料药。The traditional Chinese medicine components are pulverized, then extracted with ethanol to obtain the extract, dried, pulverized again, and the pulverized particle size is controlled at 50-90um, so that the active ingredient raw material medicine can be obtained.
(3)将(2)加入到(1)中充分搅拌,即可制备得到乳膏制剂。(3) Add (2) into (1) and stir thoroughly to prepare a cream preparation.
使用方法:将上述制备好的乳膏制剂均匀涂抹于脸上,约二十分钟后,再用清水冲洗干净即可。How to use: Apply the cream preparation prepared above evenly on the face, and after about 20 minutes, rinse it off with clean water.
实施例4本发明中药组合物的搽剂制备The liniment preparation of embodiment 4 Chinese medicine composition of the present invention
(1)将乙醇200ml(95%)、苯酚20g、硼酸50g、纯水500ml置于容器中,加热溶解,搅拌均匀后冷却,即可作为消毒剂辅料;(1) Put 200ml of ethanol (95%), 20g of phenol, 50g of boric acid, and 500ml of pure water in a container, heat to dissolve, stir evenly and then cool, then it can be used as a disinfectant auxiliary material;
(2)按下述重量配比称取各中药成分:桃花20g,冬瓜子20g,白丁香20g,山慈菇20g,重楼20g,丹参40g、白芷40g,白藓皮20g,硫磺粉10g,黄芩15g,栀子15g,银花15g,珍珠粉20g,绿豆20g。(2) each Chinese medicine composition is taken by following weight ratio: peach blossom 20g, wax gourd seed 20g, white clove 20g, mountain arrowhead 20g, polyphyllum 20g, salvia miltiorrhiza 40g, angelica dahurica 40g, white moss bark 20g, sulfur powder 10g, Scutellaria baicalensis 15g, gardenia 15g, silver flower 15g, pearl powder 20g, mung bean 20g.
将中药成分粉碎后采用水提取得到提取物,干燥,再次粉碎,粉碎粒径控制在50-90um,即可得到活性成分原料药。The traditional Chinese medicine components are pulverized and then extracted with water to obtain extracts, dried and pulverized again, and the pulverized particle size is controlled at 50-90um to obtain active ingredient raw materials.
(3)将(2)加入到(1)中搅拌均匀,即可得到具有消毒功能的治疗痤疮搽剂(具有一定的消毒功效)。(3) Add (2) into (1) and stir evenly to obtain a liniment for treating acne with a disinfection function (with a certain disinfection effect).
(4)将购置的干净面膜纸,浸渍于搽剂中10-15min,取出稍微晾干,即完成搽剂面膜制备。(4) Soak the purchased clean facial mask paper in the liniment for 10-15 minutes, take it out and let it dry slightly, and the preparation of the liniment mask is completed.
使用方法:将上述制备好的搽剂面膜均匀铺展于脸上,约二十分钟后,再用清水冲洗干净即可。How to use: Spread the liniment mask prepared above evenly on the face, and after about 20 minutes, rinse it off with clean water.
实施例5本发明中药组合物的酊剂面膜制备The tincture mask preparation of embodiment 5 Chinese medicine composition of the present invention
(1)按下述重量配比称取各中药成分:桃花20g,冬瓜子20g,白丁香20g,山慈菇20g,重楼20g,丹参40g、白芷40g,白藓皮20g,硫磺粉10g,黄芩15g,栀子15g,银花15g,珍珠粉20g,绿豆20g。(1) Take each Chinese medicine composition by following weight ratio: peach blossom 20g, wax gourd seed 20g, white clove 20g, mountain arrowhead 20g, polyphylla 20g, salvia miltiorrhiza 40g, angelica dahurica 40g, white moss bark 20g, sulfur powder 10g, Scutellaria baicalensis 15g, gardenia 15g, silver flower 15g, pearl powder 20g, mung bean 20g.
将中药成分粉碎后采用75%乙醇提取得到提取物,干燥,再次粉碎,粉碎粒径控制在50-90um,即可得到活性成分原料药。The traditional Chinese medicine components are pulverized and then extracted with 75% ethanol to obtain the extract, dried and pulverized again, and the pulverized particle size is controlled at 50-90um to obtain active ingredient raw materials.
(2)将(1)缓缓加入300ml乙醇(95%)中,搅拌均匀,即可制备得到酊剂剂型。(2) slowly add (1) into 300ml of ethanol (95%), stir evenly, and then the tincture dosage form can be prepared.
(3)将购置的干净面膜纸,浸渍于搽剂中10-15min,取出稍微晾干,即完成酊剂面膜制备。(3) Soak the purchased clean mask paper in the liniment for 10-15 minutes, take it out and let it dry slightly, and the preparation of the tincture mask is completed.
实施例6本发明中药提取物与其他药物或活性成分组合制备用于治疗痤疮的复合面膜Embodiment 6 Chinese medicine extract of the present invention is combined with other drugs or active ingredients to prepare a composite facial mask for treating acne
按下述重量配比称取各中药成分:桃花20g,冬瓜子20g,白丁香20g,山慈菇20g,重楼20g,丹参40g、白芷40g,白藓皮20g,硫磺粉10g,黄芩15g,栀子15g,银花15g,珍珠粉20g,绿豆20g。Weigh each Chinese medicine composition according to the following weight ratio: peach blossom 20g, wax gourd seeds 20g, white clove 20g, Shanzi mushroom 20g, Chonglou 20g, salvia miltiorrhiza 40g, angelica dahurica 40g, white moss bark 20g, sulfur powder 10g, scutellaria baicalensis 15g, Gardenia 15g, silver flower 15g, pearl powder 20g, mung bean 20g.
将各中药成分粉碎后采用水提取得到提取物,干燥,再次粉碎,粉碎粒径控制在50-90um,即可得到活性成分原料药。随后可采用实施例2-5中各种制剂方法进行各种剂型制备,同时加入一定量的维生素A酸(占总量的0.05%-01%),混合均匀后,即可制备得到中药组合物与维生素A酸的复合制剂,该剂型包括软膏、乳剂、搽剂、酊剂等。After pulverizing each traditional Chinese medicine component, water extraction is used to obtain an extract, dried, and pulverized again, and the pulverized particle size is controlled at 50-90um, so that the active ingredient raw material drug can be obtained. Various preparation methods in Examples 2-5 can then be used to prepare various dosage forms, and a certain amount of retinoic acid (accounting for 0.05%-01% of the total amount) is added at the same time, and after mixing evenly, the traditional Chinese medicine composition can be prepared Compound preparation with vitamin A acid, the dosage form includes ointment, emulsion, liniment, tincture, etc.
以下通过试验例具体说明本发明的有益效果。The beneficial effects of the present invention will be specifically described below through test examples.
试验例1本发明面膜治疗痤疮的临床观察Clinical observation of test example 1 facial mask of the present invention treating acne
(一)收治患者标准(或诊断标准)(1) Criteria for admitted patients (or diagnostic criteria)
患者性别及年龄范围:患者100例,年龄18~35岁,女性39例,男性61例。Gender and age range of patients: 100 patients, aged 18-35 years, 39 females and 61 males.
诊断标准:顽固性痤疮诊断参照国家中医药管理局1994年发布的《中医病证诊断疗效标准》(ZY/T001.8-94)〔4〕中的有关标准及临床实际情况制定:Diagnostic criteria: Diagnosis of intractable acne is formulated with reference to the relevant criteria and actual clinical conditions in the "Diagnosis and Curative Effect Criteria for Diseases and Syndromes of Traditional Chinese Medicine" (ZY/T001.8-94) [4] issued by the State Administration of Traditional Chinese Medicine in 1994:
1初起在毛囊口,呈现小米粒大小红色丘疹,亦可演变为脓疱。此后可形成硬结样白头粉刺或黑头粉刺,严重病例可形成硬结性囊肿。1 At the beginning of the hair follicle, red papules the size of rice grains appear, which can also develop into pustules. Thereafter, induration-like whiteheads or blackheads can be formed, and induration cysts can be formed in severe cases.
2多发于男女青春期之面部及胸背部,常伴有皮脂溢出。2 Mostly occurs on the face, chest and back of puberty men and women, often accompanied by seborrhea.
3多有饮食不节,过食肥甘厚味,或感外邪等诱发,一般无明显全身症状。3 Most of them are induced by improper diet, overeating fat, sweet and delicious food, or exogenous pathogenic factors, and generally have no obvious systemic symptoms.
中医(或西医)症状特点:临床表现为多发于面部,以丘疹、脓疱、结节有时可挤出白色碎米样粉汁为特征的一种皮肤病,皮疹红肿疼痛,或有脓疱,或结成囊肿,局部肿块刺痛,伴有胸闷多痰,舌紫暗或有斑点,苔腻,脉弦涩。Symptom characteristics of traditional Chinese medicine (or Western medicine): clinical manifestations are mainly on the face, a skin disease characterized by papules, pustules, and nodules that sometimes squeeze out white broken rice-like powder juice, rash, redness, swelling and pain, or pustules, Or form cysts, local lumps tingling, accompanied by chest tightness and phlegm, dark purple tongue or spots, greasy fur, stringy and astringent pulse.
诊断:痤疮(痰瘀互结型)Diagnosis: acne (phlegm and blood stasis type)
(二)疗效评定(2) Efficacy evaluation
参照孙传兴《临床疾病诊断依据治愈好转标准》中的有关标准拟定。It was formulated with reference to the relevant standards in Sun Chuanxing's "Clinical Disease Diagnosis Based on Cure and Improvement Standards".
标准疗效(%):(治疗前皮损数-治疗后皮损数)/治疗前皮损数×100%。Standard curative effect (%): (number of skin lesions before treatment-number of skin lesions after treatment)/number of skin lesions before treatment×100%.
临床痊愈:皮损消退90%以上,无新皮损出现;Clinical recovery: more than 90% of the skin lesions disappeared, and no new skin lesions appeared;
显效:皮损消退60-89%,基本不出新疹;Significantly effective: 60-89% of the skin lesions subside, and basically no new rashes;
有效:自觉症状明显减退,皮损消退30-59%,无新疹或仅有少许新疹发生为有效;Effective: the subjective symptoms are significantly reduced, the skin lesions subside by 30-59%, and no new rash or only a little new rash occurs; it is effective;
无效:皮损消退不足30%,症状无变化或加重为无效。Ineffective: less than 30% of the skin lesions subsided, no change or aggravation of symptoms was invalid.
总有效率=痊愈率+显效率+有效率。Total effective rate = recovery rate + marked rate + effective rate.
(三)治疗方法(3) Treatment methods
1、给药方法:1. Administration method:
明确诊断后,100例患者均采用:本发明实施例1制备的面膜。After definite diagnosis, 100 routine patients all adopted: the facial mask prepared by the embodiment 1 of the present invention.
使用方法:(1)将本发明实施例1制备的面膜涂抹于脸上,约二十分钟后,再用清水冲洗干净。Method of use: (1) Apply the facial mask prepared in Example 1 of the present invention on the face, and rinse it off with clear water after about twenty minutes.
(2)脸洗净后,用化妆棉沾取橄榄油,敷于脸上,约5分钟。(2) After washing the face, dip a cotton pad with olive oil and apply it on the face for about 5 minutes.
(3)然后再以热毛巾覆盖在脸上,此时化妆棉不需拿掉。(3) Then cover the face with a hot towel, and do not need to remove the cotton pad at this time.
(4)等毛巾冷却后,再把毛巾和化妆棉取下,洗净脸部即可。(4) Wait for the towel to cool down, then remove the towel and cotton pad, and wash your face.
给药方法:每周2-3次(每次使用的原生药量合计295g),1月为1个疗程,连用2月,治疗期间,不配有其它西药和其它疗法。Administration method: 2-3 times a week (the total amount of original medicine used each time is 295g), one month is a course of treatment, and it is used continuously for two months. During the treatment period, no other western medicine and other treatments are provided.
治疗期间饮食清淡,忌肥甘厚味,忌甜食、海鲜食物及热性水果,忌烟酒,嘱多食蔬菜。During the treatment period, the diet should be light, avoid fat, sweet and thick food, avoid sweet food, seafood and hot fruits, avoid smoking and alcohol, and ask to eat more vegetables.
2、无明显用药禁忌。2. There is no obvious drug contraindication.
(四)治疗结果(4) Treatment results
治疗时间:2个月Treatment time: 2 months
疗效判定:结果如下Efficacy judgment: the results are as follows
表1 100例患者经过2月治疗后的疗效Table 1 Curative effect of 100 patients after 2 months of treatment
经2月治疗后,100例患者中,痊愈21例,显效30例,有效36例,无效13例,总有效率达到87%。After two months of treatment, among 100 patients, 21 were cured, 30 were markedly effective, 36 were effective, and 13 were ineffective. The total effective rate reached 87%.
不良反应:用药期间未见不良反应,偶见部分患者治疗初期皮疹加重,经调整药剂后,得到缓解、控制。部分患者查血象、肝肾功能无异常。Adverse reactions: No adverse reactions were seen during the medication period. Occasionally, some patients had exacerbated skin rashes at the initial stage of treatment, which were relieved and controlled after adjusting the dosage. Some patients had no abnormality in blood examination, liver and kidney function.
由试验结果可知,痤疮患者均无不良反应,无复发现象。本发明的中药组合物对缓解痤疮尤其是顽固性痤疮包括化脓性、囊肿性痤疮患者病情疗效显著,可改善痤疮囊肿、瘢痕,有效治疗中医的痰瘀互结型痤疮。对防治痤疮的复发以及复发后的症状减轻有一定疗效。It can be seen from the test results that all acne patients had no adverse reactions and no recurrence. The traditional Chinese medicine composition of the present invention has a significant curative effect on relieving acne, especially intractable acne including suppurative and cystic acne, can improve acne cysts and scars, and effectively treat phlegm-stasis intertwined acne in traditional Chinese medicine. It has a certain effect on the prevention and treatment of acne recurrence and the relief of symptoms after recurrence.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510147846.2A CN104740320A (en) | 2015-03-31 | 2015-03-31 | Traditional Chinese medicine composition for treating acne and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510147846.2A CN104740320A (en) | 2015-03-31 | 2015-03-31 | Traditional Chinese medicine composition for treating acne and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104740320A true CN104740320A (en) | 2015-07-01 |
Family
ID=53580940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510147846.2A Pending CN104740320A (en) | 2015-03-31 | 2015-03-31 | Traditional Chinese medicine composition for treating acne and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104740320A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940112A (en) * | 2015-07-03 | 2015-09-30 | 任晓明 | Antiseptic and anti-acne traditional Chinese medicine face mask and preparation method thereof |
CN105412502A (en) * | 2015-12-16 | 2016-03-23 | 济南舜祥医药科技有限公司 | Ointment for nasal acne pustulosa of man and preparation method of ointment |
CN108354879A (en) * | 2018-04-11 | 2018-08-03 | 杨燕富 | A kind of aseptic face cream of anti-acne and preparation method thereof |
-
2015
- 2015-03-31 CN CN201510147846.2A patent/CN104740320A/en active Pending
Non-Patent Citations (1)
Title |
---|
徐娟: "《完美女人保养手册》", 30 June 2006 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940112A (en) * | 2015-07-03 | 2015-09-30 | 任晓明 | Antiseptic and anti-acne traditional Chinese medicine face mask and preparation method thereof |
CN105412502A (en) * | 2015-12-16 | 2016-03-23 | 济南舜祥医药科技有限公司 | Ointment for nasal acne pustulosa of man and preparation method of ointment |
CN108354879A (en) * | 2018-04-11 | 2018-08-03 | 杨燕富 | A kind of aseptic face cream of anti-acne and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104740321A (en) | Traditional Chinese medicine composition for removing chloasma and preparation method thereof | |
CN104411320A (en) | Composition comprising natural extracts as active ingredients for improving condition of hair and scalp, and method for preparing same | |
CN108938759B (en) | A kind of medicine or daily chemical composition for treating hand-foot syndrome and preparation method and use thereof | |
CN104740320A (en) | Traditional Chinese medicine composition for treating acne and preparation method thereof | |
CN112807409B (en) | A traditional Chinese medicine composition for external treatment of Hashimoto's thyroiditis and thyroid nodules and its application | |
CN106266830A (en) | A kind of Chinese medicine composition treating eczema | |
CN105232606B (en) | A kind of external pharmaceutical composition for acne treatment and preparation method thereof | |
Abdelhalim et al. | Medicinal plants used for women's healthcare in Al-Madinah Al-Munawarah, Saudi Arabia | |
CN103751245B (en) | One treats dermopathic Chinese medicine composition and uses thereof | |
CN109125641A (en) | Compound cortex dictamni ointment and preparation method thereof | |
CN108434225A (en) | A kind of Chinese medicine composition and its preparation method and application for treating senile skin itch | |
CN105726946A (en) | Anti-recurrence traditional Chinese medicine anti-acne repair cream | |
CN104352944B (en) | A kind of pharmaceutical composition for acne | |
CN103520353B (en) | Medicament for treating urticaria, and preparation method and application thereof | |
CN103920124B (en) | A kind of bactericidal skin care ointment for frostbite | |
CN108686157B (en) | Traditional Chinese medicine composition for preventing and treating blood stasis type nodules of breast, preparation method and pharmaceutical preparation thereof | |
CN106389136A (en) | Plant nanoemulsion acne cream | |
CN107669576B (en) | Cosmetic composition for improving hyperplasia of mammary glands and preventing breast diseases | |
CN105412731A (en) | Ointment for treating skin pruritus and preparing method thereof | |
WO2019142042A1 (en) | Synergistic medicinal preparation for treating skin disorders like tinea versicolor | |
CN110075178A (en) | A kind of composition for treating corticosteroid dermatitis, preparation and preparation method and application | |
CN104940524B (en) | It is a kind of to be used to treat drug of leucoderma and preparation method thereof | |
CN110051803A (en) | Pharmaceutical composition, preparation and its preparation method application for treating psoriasis vulgaris | |
CN106266152A (en) | A kind of pharmaceutical composition for treating eczema and its preparation method and application | |
CN115779025B (en) | Traditional Chinese medicine preparation for treating female acne and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150701 |
|
RJ01 | Rejection of invention patent application after publication |